The following data is part of a premarket notification filed by Bayer Corp. with the FDA for Dca 2000 + Microalbumin/creatinine Assay.
Device ID | K963142 |
510k Number | K963142 |
Device Name: | DCA 2000 + MICROALBUMIN/CREATININE ASSAY |
Classification | Indicator Method, Protein Or Albumin (urinary, Non-quant.) |
Applicant | BAYER CORP. 1884 MILES AVE. P.O. BOX 70 Elkhart, IN 46514 -0070 |
Contact | Rosanne M Savol, R.a.c. |
Correspondent | Rosanne M Savol, R.a.c. BAYER CORP. 1884 MILES AVE. P.O. BOX 70 Elkhart, IN 46514 -0070 |
Product Code | JIR |
CFR Regulation Number | 862.1645 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 1996-08-13 |
Decision Date | 1996-09-27 |
Summary: | summary |
Device Identifier | submissionNumber | Supplement |
---|---|---|
00630414535722 | K963142 | 000 |
00630414532790 | K963142 | 000 |
00630414027364 | K963142 | 000 |